Lemaitre Vascular Inc (LMAT): who owns it and who trades it
As of Nov 16, 2026, LMAT insiders reported 11 open-market sales worth $30M and no purchases in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was George W LeMaitre (CEO), with $27.1M. 5 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Lemaitre Vascular
From the latest filingsOverall: more selling than buying. Insiders mostly sold. Famous investors mostly bought. Funds was close to even.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns LMAT
324 funds and institutions reported LMAT shares worth $2.2B at the end of Q2 2026. Some shares are counted by more than one filer, or lent out and counted twice, so the total can pass 100%. The largest holder is BlackRock, Inc. with 14.3%.
Funds and institutions (13F) about 100%Everyone else 0%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 3.27M | 14.32% | $314M | +4% |
| Conestoga Capital Advisors, LLC | 1.37M | 5.98% | $131M | -7% |
| First Trust Advisors LP | 1.09M | 4.79% | $105M | +10% |
| Congress Asset Management Co | 963,706 | 4.22% | $92.5M | +15% |
| Vanguard Capital Management LLC | 953,437 | 4.17% | $91.5M | +5% |
| State Street Corp | 901,416 | 3.94% | $86.5M | +5% |
| Copeland Capital Management, LLC | 839,463 | 3.67% | $80.6M | -4% |
| Geode Capital Management, LLC | 788,835 | 3.45% | $75.7M | +20% |
| T. Rowe Price Associates | 755,142 | 3.30% | $72.5M | +156% |
| Vanguard Portfolio Management LLC | 604,833 | 2.65% | $58M | +7% |
| Geneva Capital Management LLC | 589,064 | 2.58% | $56.5M | -22% |
| Dimensional Fund Advisors LP | 493,889 | 2.16% | $47.4M | +4% |
| Goldman Sachs Group Inc | 473,194 | 2.07% | $45.4M | +9% |
| Invesco Ltd. | 448,389 | 1.96% | $43M | +34% |
| Morgan Stanley | 351,083 | 1.54% | $33.7M | -14% |
| Northern Trust Corp | 333,325 | 1.46% | $32M | +7% |
| Two Sigma Investments, LP | 316,528 | 1.39% | $30.4M | +12% |
| Royal Bank of Canada | 308,765 | 1.35% | $29.6M | +13% |
| Annex Advisory Services, LLC | 248,253 | 1.09% | $23.8M | -1% |
| UBS Group AG | 247,804 | 1.08% | $23.8M | +498% |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, LMAT insiders reported $0 of open-market purchases and $30M of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2026 | George W LeMaitre | CEO | Sale | 27,881 | $108.69 | $3M | Form 4 |
| May 8, 2026 | Trent G Kamke | Senior V. P. | Sale | 2,928 | $107.00 | $313K | Form 4 |
| May 7, 2026 | George W LeMaitre | CEO | Sale | 18,600 | $107.64 | $2M | Form 4 |
| May 7, 2026 | Bridget A Ross | Director | Sale | 5,044 | $111.10 | $560K | Form 4 |
| May 7, 2026 | Lawrence J Jasinski | Director | Sale | 3,943 | $110.00 | $434K | Form 4 |
| Mar 11, 2026 | Trent G Kamke | Senior V. P. | Sale | 2,625 | $108.50 | $285K | Form 4 |
| Mar 11, 2026 | David B Roberts | President | Sale | 3,312 | $107.68 | $357K | Form 4 |
| Mar 2, 2026 | George W LeMaitre | CEO | Sale | 55,930 | $107.81 | $6M | Form 4 |
| Feb 27, 2026 | Trent G Kamke | Senior V. P. | Sale | 1,044 | $110.29 | $115K | Form 4 |
| Feb 27, 2026 | David B Roberts | President | Sale | 8,464 | $106.80 | $904K | Form 4 |
| Feb 26, 2026 | George W LeMaitre | CEO | Sale | 150,000 | $106.76 | $16M | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| George W LeMaitre | Chairman and CEO, Director | – | $27.1M | May 8, 2026 |
| David B Roberts | President and Director, Director | – | $1.3M | Mar 11, 2026 |
| Trent G Kamke | Senior V. P., Operations | – | $713K | May 8, 2026 |
| Bridget A Ross | Director | – | $560K | May 7, 2026 |
| Lawrence J Jasinski | Director | – | $434K | May 7, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LMAT short interest
Moderate short interest. 7.2% of LMAT shares are sold short: about 1 share in 14. Over the last 12 reports the number of shares short went up 44%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 1.66M LMAT shares were sold short, 7.2% of the shares outstanding, down 6.7% from the report before. At the average daily volume of 268,701 shares, buying them all back would take about 6.2 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 1.66M | 7.24% | -7% | 268,701 | 6.2 |
| Oct 15, 2026 | 1.78M | 7.77% | +2% | 270,391 | 6.6 |
| Sep 30, 2026 | 1.74M | 7.60% | +3% | 253,231 | 6.9 |
| Sep 15, 2026 | 1.69M | 7.40% | +11% | 268,425 | 6.3 |
| Aug 31, 2026 | 1.52M | 6.65% | -5% | 318,109 | 4.8 |
| Aug 14, 2026 | 1.61M | 7.04% | +11% | 585,995 | 2.8 |
| Jul 31, 2026 | 1.45M | 6.33% | -2% | 258,683 | 5.6 |
| Jul 15, 2026 | 1.48M | 6.48% | +9% | 328,722 | 4.5 |
| Jun 30, 2026 | 1.36M | 5.94% | +6% | 408,267 | 3.3 |
| Jun 15, 2026 | 1.28M | 5.59% | +8% | 292,250 | 4.4 |
| May 29, 2026 | 1.19M | 5.20% | +3% | 318,465 | 3.7 |
| May 15, 2026 | 1.15M | 5.05% | -1% | 309,933 | 3.7 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Lemaitre Vascular company events
Lemaitre Vascular filed 7 reports on Form 8-K in the last 12 months, 2 of them about an important change (leadership). The latest was on Nov 4, 2026.
- Nov 4, 2026ResultsReleased financial results. Filing
- Oct 15, 2026LeadershipDavid B. Roberts notified LeMaitre Vascular, Inc. of his intent to retire as an employee of the Company, including as its President, effective as of December 31, 2026. Filing
- Aug 4, 2026ResultsReleased financial results. Filing
- Jun 5, 2026VoteReported shareholder vote results. Filing
- May 5, 2026ResultsReleased financial results. Filing
- Apr 14, 2026LeadershipBridget Ross notified the Board of Directors of LeMaitre Vascular, Inc. of her intent not to stand for re-election as a Class II director of the Company at the Company’s 2026 Annual Meeting of Stockholders to be held on June 2, 2026. Filing
- Feb 25, 2026ResultsReleased financial results. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Lemaitre Vascular financials
Famous investors that hold LMAT
5 of the 50 well-known investors we track reported holding LMAT in their latest 13F filing. The largest position is Ken Griffin's, worth $50M.
Position size
All holders
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Ken Griffin · Citadel Advisors | Q3 2026 | 605,346 | $50M | 0.0% | +1313% |
| Steve Cohen · Point72 Asset Management | Q3 2026 | 75,987 | $6.3M | 0.0% | New |
| Paul Tudor Jones · Tudor Investment Corp | Q3 2026 | 40,897 | $3.4M | 0.0% | -54% |
| Israel Englander · Millennium Management | Q3 2026 | 15,594 | $1.3M | 0.0% | +73% |
| Jim Simons · Renaissance Technologies | Q3 2026 | 11,602 | $958K | 0.0% | -93% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Lemaitre Vascular Inc (LMAT) stock
Who owns the most LMAT stock?
The largest reported owner of Lemaitre Vascular Inc (LMAT) is BlackRock, Inc., with 14.3% of the company. In total, 324 funds and institutions reported holding LMAT at the end of Q2 2026, together about 100% of the shares. See the largest owners.
Are LMAT insiders buying or selling?
In the last 12 months, LMAT insiders reported no open-market purchases and 11 sales worth $30M. The latest trade was on May 8, 2026. See every trade.
What is the short interest in LMAT?
As of Oct 30, 2026, 1.66M LMAT shares were sold short, 7.2% of the shares outstanding, down 6.7% from the report before. At the average daily volume of 268,701 shares, buying them all back would take about 6.2 trading days (days to cover). See the history.
Which famous investors hold LMAT?
5 of the 50 well-known investors we track reported LMAT in their latest 13F filing, including Ken Griffin, Steve Cohen, Paul Tudor Jones. The largest position is worth $50M. See all holders.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.